The multidisciplinary approach to hemodialysis vascular access at the Mount Sinai hospital

Mount Sinai Journal of Medicine

Volumn 71, Issue 2, 2004, Pages 94-102

  Vassalotti, Joseph A ^a   Falk, Abigail ^a   Teodorescu, Victoria ^a   Uribarri, Jaime ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Division of Nephrology   (United States)

Author keywords

AV fistula; Catheter; Dialysis; Distal revascularization interval ligation; Doppler ultrasound; Graft; Static venous pressure; Thrombolysis; Vein mapping

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; CLOPIDOGREL; DIPYRIDAMOLE; FISH OIL;

ANEURYSM SURGERY; ARTERIOVENOUS FISTULA; ARTERY STEAL SYNDROME; CATHETER INFECTION; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; FALSE ANEURYSM; GRAFT INFECTION; GRAFT OCCLUSION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; NEPHROLOGY; NURSE; OUTPATIENT DEPARTMENT; PATIENT CARE; PHYSICIAN ASSISTANT; PREOPERATIVE EVALUATION; REVASCULARIZATION; REVIEW; SCREENING TEST; SURGEON; THROMBOSIS; TREATMENT OUTCOME; UNITED STATES; VASCULAR ACCESS; VASCULAR SURGERY;

ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PATIENT CARE TEAM; RADIOGRAPHY, INTERVENTIONAL; RENAL DIALYSIS; ULTRASONOGRAPHY, DOPPLER;

EID: 1642377112     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. US Renal Data System, USRDS 2002 Annual data report: Atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2002.
2. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7:523-535.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for vascular access, 2000. Am J Kid Dis 2001; 37(Suppl 1):S137-S181.
4. Tokars JI, Frank M, Alter MJ, et al. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002; 15:162-171.
5. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002; 61:305-316.
6. Work J. Chronic catheter placement. Semin Dial 2001; 14:436-440.
7. Gray RJ, Levitin A, Buck D, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous catheters: A prospective, randomized trial. J Vasc Interv Radiol 2000; 11:1121-1129.
8. Little MA, Walshe JJ. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction. Am J Kidney Dis 2002; 39:86-91.
9. Miller PE, Tolwani A, Luscy CP, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56:275-280.
10. Paulson WD, Ram SJ, Zibari GB. Vascular access: Anatomy, examination, management. Semin Nephrol 2002; 22:183-194.
11. Falk A, Teodorescu V, Mitty HA, et al. "SWing point stenoses" In hemodialysis arteriovenous fistulae [abstract]. J Vasc Interv Radiol 2001; 12:S52A.
12. Turmel-Rodrigues L, Raynaud A, et al. Manual catheter-directed aspiration and other thrombectomy techniques for declotting native fistulas for hemodialysis. J Vasc Interv Radiol 2001; 12:1365-1371.
13. Falk A, Guller J, Nowakowski S, et al. Reteplase in the treatment of thrombosed hemodialysis grafts. J Vasc Interv Radiol 2001; 12:1257-1262.
14. Falk A, Mitty H, Guller J, et al. Thrombolysis of clotted hemodialysis grafts with tissue-type plasminogen activator. J Vasc Interv Radiol 2001; 12:305-311.
15. Stanley JC, Barnes RW, Ernst CB, et al. Vascular surgery in the United States: Workforce issues. Report of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery, North American Chapter, Committee on Workforce Issues. J Vasc Surg 1996; 23:172-181.
16. Held PJ, Port FK, Webb RL, et al. Excerpts from United States Renal Data System 1995 Annual Data Report. Am J Kidney Dis 1995; 26(4 Suppl 2): S1-186.
17. Silva MB Jr, Hobson RW 2nd, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27:302-308.
18. Robbin ML, Gallichio MH. Deierhoi MH, et al. US vascular mapping before hemodialysis access placement. Radiology 2000; 217:83-88.
19. Allon M, Lockhart ME, Lilly RZ, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 200; 60:2013-2020.
20. Sedlacek M, Teodorescu V, Falk A, et al. Hemodialysis access placement with preoperative noninvasive vascular mapping: Comparison between patients with and without diabetes. Am J Kidney Dis 2001; 38:560-564.
21. Vassalotti JA, Falk A, Cohl ED, et al. Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clinical Nephrol 2002; 58:211-214.
22. Westerband A, Mills JL, Kistler S, et al. Prospective validation of threshold criteria for intervention in infrainguinal vein grafts undergoing duplex surveillance. Ann Vasc Surg 1997; 11:44-48.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1):S1-S222.
24. Morsy AH, Kulbaski M, Chen C, et al. Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure. J Surg Res 1998; 74:8-10.
25. Haimov M, Schanzer H, Skladani M. Pathogenesis and management of upper-extremity ischemia following angioaccess surgery. Blood Purif 1996; 14:350-354.
26. Schanzer H, Schwartz M, Harrington E, et al. Treatment of iBchemia due to "sTeal" by arteriovenous fistula with distal artery ligation and revascularization. J Vasc Surg 1988; 7:770-773.
27. Wixon CL, Mills JL, Sr, Berman SS. Distal revascularization-interval ligation for maintenance of dialysis access and restoration of distal perfusion in ischemic steal syndrome. Semin Vasc Surg 2000; 13:77-82.
28. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6):461-470.
29. http://www.kidney.org/professionals/doqi/gfr_calculator.cfm
30. Stehman-Breen CO, Sherrard DJ, Gillen D, et al. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int 2000; 57:639-645.
31. Marr KA, Kong L, Fowler VG, et al. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 1998; 54:1684-1689.
32. Schenk P, Rosenkranz AR, Wolfl G, et al. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Am J Kidney Dis 2000; 35:130-136.
33. Mokrzycki MH, Jean-Jerome K, Rush H, et al. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 2001; 59:1935-1942.
34. Sehgal AR, Leon JB, Siminoff LA, et al. Improving the quality of hemodialysis treatment. A community-based randomized controlled trial to overcome patient-specific barriers JAMA. 2002; 287:1961-1967.
35. Dhingra RK, Young EW, Hulbert-Shearon TE, et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001; 60:1443-1451.
36. Schwab SJ, Weiss MA, Rushton F, et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int 2002; 62:1026-1033.
37. Miller PE, Carlton D, Deierhoi MH, et al. Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 2000; 36:68-74.
38. Besarab A, Sullivan KL, Ross RP, et al. Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int 1995; 47:1364-1373.
39. Dember LM, Holmberg EF, Kaufman JS. Value of static venous pressure for predicting arteriovenous graft thrombosis. Kidney Int 2002; 61:1899-1904.
40. McCarley P, Wingard RL, Shyr Y, et al. Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int 2001; 60:1164-1172.
41. Sreedhara R, Himmelfarb J, Lazarus JM, et al. Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study. Kidney Int 1994; 45:1477-1483.
42. Schmitz PG, McCloud LK, Reikes ST, et al. Prophylaxis of hemodialysis graft thrombosis with fish oil: Double-blind, randomized, prospective trial. J Am Soc Nephrol 2002; 13:184-190.
43. Kaufman J, O'Connor T, Cronin R, et al. Combination aspirin plus clopidogrel in the prevention of hemodialysis access graft thrombosis [abstract]. J Am Soc Nephrol 2001; 12:291A.
44. Crowther MA, Clase CM, Margetts PJ, et al. Low-intensity warfarin is ineffective for the prevention of PTFE Graft failure in patients on hemodialysis: A randomized controlled trial. J Am Soc Nephrol 2002; 13:2331-2337.
45. LeSar CJ, Merrick HW, Smith MR. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg 1999; 189:73-79.
46. Friedman AL, Walworth C. Meehan C, et al. First hemodialysis access selection varies with patient acuity. Adv Ren Replace Ther 2000;7(4 Suppl 1):S4-S10.
47. Allon M, Bailey R, Ballard R, et al. A multidisciplinary approach to hemodialysis access: Prospective evaluation. Kidney Int 1998; 53:473-479.
48. Kalman PG, Pope M, Bhola C, et al. A practical approach to vascular access for hemodialysis and predictors of success. J Vasc Surg 1999; 30:727-733.